4OGA | Insulin in complex with Site 1 of the human insulin receptor | date | |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Lawrence, M.C., Menting, J.G. | ||||||||||||||||||
compound | source | ||||||||||||||||||
symmetry |
| ||||||||||||||||||
crystal cell |
| ||||||||||||||||||
method | X-Ray Diffraction | resolution | 3.50 | ||||||||||||||||
ligand | BMA, FUC, MAN, NAG | enzyme |
| ||||||||||||||||
Gene Ontology |
| ||||||||||||||||||
Primary reference | Protective hinge in insulin opens to enable its receptor engagement., Menting JG, Yang Y, Chan SJ, Phillips NB, Smith BJ, Whittaker J, Wickramasinghe NP, Whittaker LJ, Pandyarajan V, Wan ZL, Yadav SP, Carroll JM, Strokes N, Roberts CT Jr, Ismail-Beigi F, Milewski W, Steiner DF, Chauhan VS, Ward CW, Weiss MA, Lawrence MC, Proc Natl Acad Sci U S A. 2014 Aug 4. pii: 201412897. PMID:25092300 |
Data retrieval |
View 4OGA in 3D |
Visual 3D analysis of 4OGA |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4OGA |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |